Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions

Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions

Bibliographic Details
Main Authors:	Barry D. Greenberg, Cynthia A. Lemere, Lisa L. Barnes, Kathleen M. Hayden, Walter A. Kukull, Esther S. Oh, Peter J. Snyder, Mark Supiano, Peggye Dilworth‐Anderson
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Online Access:	https://doi.org/10.1002/trc2.12426

Similar Items

Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions”
by: Sam Gandy
Published: (2023-10-01)

Commentary on Greenberg et al., “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” [Alzheimer's Dement. 2023; 9(4):e12426. doi.org/10.1002/trc2.12426]
by: Carl V. Hill, et al.
Published: (2024-01-01)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
by: Yara Mashal, et al.
Published: (2022-07-01)

The situations and strategies of amyloid⁃β⁃directed passive immunotherapy for Alzheimer's disease
by: Ya LI, et al.
Published: (2019-12-01)

NEXT GENERATION ALZHEIMER’S IMMUNOTHERAPY AND DIAGNOSIS TARGETING NEUROTOXIC AMYLOID BETA OLIGOMERS.
by: William Klein
Published: (2023-10-01)

Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration
by: Tan, Chin Hong, et al.
Published: (2020)

Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
by: Thomas Gabriel Schreiner, et al.
Published: (2024-05-01)

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
by: Lambracht-Washington D, et al.
Published: (2013-08-01)

Microbial-generated amyloids and Alzheimer’s disease (AD)
by: James M Hill, et al.
Published: (2015-02-01)

Amyloid-β Peptide-targeting Immunotherapy in Alzheimer Disease: A Systematic Review of Clinical Studies
by: Haideh Mosleh, et al.
Published: (2024-10-01)

Anti-amyloid immunotherapy in Alzheimer’s disease: The new dawn emerging from 179 clinical trials
by: Longmin Fan, et al.
Published: (2024-10-01)

Amyloid fibril formation in Alzheimer's disease
by: Jarrett, Joseph Timothy
Published: (2012)

Mitochondrial β-amyloid in Alzheimer's disease.
by: Borger, E, et al.
Published: (2011)

Clinical amyloid imaging in Alzheimer's disease.
by: Herholz, K, et al.
Published: (2011)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer’s disease and cerebrovascular disease pathologies
by: Yuriko Katsumata, et al.
Published: (2018-12-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
by: Pimplikar, Sanjay W., et al.
Published: (2015)

Amyloid blood biomarker detects Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2018-04-01)

The amyloid hypothesis of Alzheimer's disease at 25 years
by: Dennis J Selkoe, et al.
Published: (2016-03-01)

Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?
by: Anna Duda-Madej, et al.
Published: (2024-05-01)

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
by: Lorena García-Vallés, et al.
Published: (2022-11-01)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
by: Olivia M. Osborne, et al.
Published: (2023-08-01)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
by: Nnana Amakiri, et al.
Published: (2019-05-01)

Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.
by: Alex E Roher, et al.
Published: (2013-01-01)

Alzheimer's Progenitor Amyloid‐β Targets and Dissolves Microbial Amyloids and Impairs Biofilm Function
by: Syed Aoun Ali, et al.
Published: (2023-10-01)

A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro‐meso‐macro perspective
by: María P. Aranda, et al.
Published: (2023-04-01)

Amyloid-β (Aβ) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer’s disease
by: Xavier Taylor, et al.
Published: (2024-10-01)

Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
by: Matthew D. Howe, et al.
Published: (2024-07-01)

Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer’s disease mice
by: Xavier Taylor, et al.
Published: (2023-08-01)

FEASIBILITY AND SAFETY OF LONG-TERM INTRATHECAL PSEUDODELIVERY OF IMMUNOTHERAPY FOR SELECTIVE CLEARANCE OF CSF AMYLOID-Β IN A MOUSE MODEL OF ALZHEIMER’S DISEASE
by: Ester Pérez-Martín, et al.
Published: (2023-10-01)

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
by: Benjamin M. Doherty, et al.
Published: (2015-06-01)

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
by: Fernando Gonzalez-Ortiz, et al.
Published: (2024-04-01)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
by: Charles G. Withington, et al.
Published: (2022-03-01)

Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
by: Høilund-Carlsen, Poul F., et al.
Published: (2024)

The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
by: Muirhead, K, et al.
Published: (2010)

Target tau, not amyloid, to prevent and treat Alzheimer’s disease
by: Esiri, MM
Published: (2020)

Folding simulation of amyloid β-peptide in alzheimer's disease.
by: Koh, Jessica Li Jian.
Published: (2010)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Amyloid-beta and tau protein beyond Alzheimer’s disease
by: Morteza Abyadeh, et al.
Published: (2024-01-01)